Navigation Links
Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
Date:11/6/2008

c agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: early results from our clinical trial, Access' plans to continue and initiate clinical trials, the value of its products in the market, its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
2. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
3. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
4. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
5. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
6. NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population
7. Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
8. AMT Starts Collaboration With St. Jude Childrens Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
9. Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.
10. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
11. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... THOUSAND OAKS, Calif. , July 27, 2015 /PRNewswire/ ... will report its second quarter financial results on Thursday, ... financial markets. The announcement will be followed by a ... PT. Participating in the call from Amgen will be ... officer, and other members of Amgen,s senior management team. ...
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, 2015 /PRNewswire/ ... health care services and one of the largest ... that its parent company and sole stockholder, Capella ... Medical Properties Trust, Inc. ("MPT") (NYSE: MPW ... cash.  The transaction is expected to be finalized ...
(Date:7/27/2015)... Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), ... treatment of cancer, today provides the following financial update. ... $1,000,000 unit offering private placement.  This financing is a ... at a price of $0.06 per unit.  Each unit ... share purchase warrant.  Each whole warrant is exercisable into ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... the Biophotonics industry.The report provides a basic overview of the industry including definitions, ... the international markets including development trends, competitive landscape analysis, and key regions development ...
Breaking Biology Technology:Amgen Announces Webcast of 2015 Second Quarter Financial Results 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Quest PharmaTech Closes $1,000,000 Private Placement 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3
... disease detection facility, developed by the University of Leicester, ... in Leicester Royal Infirmary,s A&E department. It is ... disease without the use of invasive probes, blood tests, ... three different types of cutting-edge technology in combination under ...
... Researchers at Duke University Medical Center, Beth Israel Deaconess Medical ... HIV vaccine design that uses an altered form of HIV,s ... showed that they could design HIV envelopes that could bind ... immune response in an animal model. Immature B cells are ...
... , Porphyrins are organic molecules that appear in the ... and have a metal atom ,at their center that ... ,in the field of molecular electronics lies in their ... explains the responsible of the work at the Nanomaterials ...
Cached Biology Technology:Leicester scientists deploy space-age technologies at science-fiction style 'sick bay' 2Leicester scientists deploy space-age technologies at science-fiction style 'sick bay' 3Leicester scientists deploy space-age technologies at science-fiction style 'sick bay' 4New HIV vaccine approach targets desirable immune cells 2New HIV vaccine approach targets desirable immune cells 3The quantum tunneling effect leads electron transport in porphyrins 2
(Date:7/27/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that Huawei has selected the Synaptics ® ... stylish smartwatch. Huawei chose the state-of-the-art ClearPad capacitive ... and highly responsive human interface qualities such as ... required a classic round watch face and Synaptics ...
(Date:7/27/2015)... 2015   Zynx Health ™, the market ... solutions, today announced that its ZynxCarebook ™ ... Android smartphones and tablets. With this expansion, care ... use ZynxCarebook to securely exchange messages and share ... transitions to other care settings, and improve clinical ...
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... of the past decade such as the 2003 SARS ... deaths, and the 2009 H1N1 flu pandemic that killed about ... or bacteria could spread quickly across the globe, aided by ... complex network systems such as contagion patterns and information ...
... 16, 2012, Chikyu, operations in the second part of ... Drilling Project (JFAST), achieved another objective by installing temperature ... infers the fault slipped during the 2011 Tohoku Earthquake. ... scientific drilling vessel Chikyu to meet the challenge of ...
... Using recent advances in marine biomechanics, materials science, and ... and the California Institute of Technology (Caltech) have turned ... freely swimming "jellyfish." The finding serves as a ... muscular organs and simple life forms. It also suggests ...
Cached Biology News:New model of disease contagion ranks US airports in terms of their spreading influence 2New model of disease contagion ranks US airports in terms of their spreading influence 3Return to the Japan Trench 2Return to the Japan Trench 3Artificial jellyfish swims in a heartbeat 2Artificial jellyfish swims in a heartbeat 3Artificial jellyfish swims in a heartbeat 4
Economical and manually filled LN2 vacuum insulated storage container offers high capacity and low nitrogen consumption while offering convenient storage of samples....
... DNase I Amplification ... double-stranded DNA to oligodeoxyribonucleotides. ... >10000 units/mg. DNAse I ... purified and tested for ...
... Collection of Cell Cultures (ECACC) in conjunction ... the West of England, Bristol, UK, have ... control of HER2, oestrogen and progresterone receptor ... sections of formalin fixed, breast cancer cell ...
... protease from human rhinovirus (HRV 3C) is ... line of restriction grade proteases. The recombinant ... protein, which recognizes the same cleavage site ... 22 KDa size of the protease, optimal ...
Biology Products: